Third Harmonic Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell THRD and other ETFs, options, and stocks.

About THRD

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases.

CEO

Natalie C. Holles

CEONatalie C. Holles

Employees

Employees53

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2019

Founded2019

Employees

Employees53

THRD Key Statistics

Market cap

231.63M

Market cap231.63M

Price-Earnings ratio

-4.74

Price-Earnings ratio-4.74

Dividend yield

—

Dividend yield—

Average volume

1.93M

Average volume1.93M

High today

$5.15

High today$5.15

Low today

$5.12

Low today$5.12

Open price

$5.12

Open price$5.12

Volume

166.61K

Volume166.61K

52 Week high

$16.94

52 Week high$16.94

52 Week low

$3.18

52 Week low$3.18

Third Harmonic Bio

Why Robinhood?

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. Show more

THRD Key Statistics

Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases.